News

ELITechGroup

Filter

Open filter menu
Reset
Reset

Alkaline Phosphatase (ALP) based on IFCC recommendations

Alkaline Phosphatase, ALP based on IFCC recommendations
What is Alkaline Phosphatase (ALP)? A common clinical chemistry laboratory test that measures the level of the enzyme Alkaline Phosphatase (ALP) in the blood. ALP is present in almost all forms of life and is thought to have a role in the provision of phosphate to tissue or the activation/inactivation…

Easy-to-use economical solution for measuring Lipids

Easy-to-use economical Lipids testing in clinical laboratory
Why test Lipids? Lipids and lipoprotein particles crucially contribute to coronary artery disease and influence inflammatory processes as well as the function of leukocytes, vascular and cardiac cells, thereby impacting vessels and the heart.(1) Cholesterol and triglycerides are lipids that are insoluble in plasma and measuring lipids, and lipoproteins have…

ELITechGroup Clinical Chemistry Introduces eLITROL SelectQC™

Internal Quality Control program eLITROL SelectQC for real time IQC
ELITechGroup Clinical Chemistry Introduces eLITROL SelectQC™ – A Comprehensive Web-Based IQC Platform for Selectra System Users ELITechGroup Clinical Chemistry is proud to announce the launch of eLITROL SelectQC™, a new web-based internal quality control (IQC) platform designed for all Selectra System users in clinical chemistry laboratories. The platform offers comprehensive…

ELITechGroup’s Vitamin D reagents; ready-to-use chemistry for efficiency

Vitamin D testing for clinical laboratory
Vitamin D is a fat-soluble steroid hormone that is required for the intestinal absorption of calcium, maintenance of calcium homeostasis, and protection against osteomalacia i.e. softening of the bones. Vitamin D deficiency can lead to loss of bone density which can contribute to osteoporosis (reduction in bone mass) and fractures…

ELITechGroup’s Cholinesterase – an economical option for low-volume testing

Cholinesterase assay for low-volume testing
The primary role of Cholinesterase in Clinical Diagnostics is to detect or monitor an acquired or inherited pseudocholinesterase deficiency. Pseudocholinesterase deficiency is a condition that causes increased sensitivity to certain muscle relaxant drugs used during general anesthesia (choline esters). These drugs relax the muscles used for movement, including those used…

ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories

ELITechGroup and InfanDx collaboration
HypoxE® Test allows for the early detection of Hypoxic-Ischemic Encephalopathy (HIE) caused by lack of oxygen during birth ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of clinical chemistry analyzers Chicago, IL, USA, July 27, 2022 – ELITechGroup and InfanDx AG…

IVDR compliance at ELITechGroup Clinical Chemistry

In Vitro Diagnostic reagents for clinical chemistry
As a European-based (EU) manufacturer of IVD products, used in clinical diagnostic laboratories throughout the world, the introduction of the EU’s IVDR is of paramount importance for ELITechGroup’s Clinical Systems division. European Invitro Diagnostic Medical Device Regulations (IVDR) The IVDR will replace the existing In Vitro Diagnostic Medical Devices Directive…

NEW ELITechGroup Lactate Reagent

Lactate reagent for clinical laboratory testing
ELITechGroup Clinical Systems is pleased to announce the introduction of another new reagent, Lactate, to the growing range of reagents for the Selectra Pro and Mach systems. Lactate is a metabolite of glucose, produced during conditions of insufficient oxygen supply (e.g. rapid exercise). Most Lactate is produced by skeletal muscle…

NGSP Recertification of HbA1c methods for Selectra Pro M and Pro S

Fully automated biochemistry analyzer Selectra ProM
According to the 9th Edition of the IDF Diabetes Atlas 463 million adults (20-79 years) have Diabetes and based on current trends this number is expected to reach 700 million by 2045. ​It is estimated almost 232 million people have undiagnosed diabetes (2019). ​So, it is not surprising that Diabetes…

Hospital Artificial Intelligence

Artificial intelligence (AI) is being utilized in many different walks of life these days to improve people’s lives. From vehicles that are able to drive themselves to smartphones that react to the commands people give them and provide them with the information they need, AI has come a long way…

New Heart Failure Treatment Possibility

The number of people suffering from heart failure is expected to increase almost 50 percent over the course of the next 15 years. This is very troubling because, as of right now, about half of those who suffer from heart failure die within five years of being diagnosed. Their heart…